PMCB 1.93 (+2.66%)
US71715X2036BiotechnologyBiotechnology

PharmaCyte Biotech (PMCB) Stock Highlights

1.93 | +2.66%
2024-09-19 07:03:05
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Statistics

Range Today
1.78 2.11
Volume Today 19K
Range 1 Year
1.39 2.6
Volume 1 Year 5.04M
Range 3 Year
1.39 3.54
Volume 3 Year 119.79M
Range 10 Year
1.39 418.5
Volume 10 Year 541.73M

Highlights

Market Capitalization 14.65M (micro)
Floating Shares 7.32M
Current Price 1.93
Price To Earnings -1.02
Price To Book 0.55
Earnings Per Share -1.8
Payout Ratio 0%

Performance

Latest +2.66%
1 Month +5.46%
3 Months -11.87%
6 Months -0.52%
1 Year -17.87%
3 Years -43.4%
5 Years -96.84%
10 Years -99.3%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.